Abteilung Epidemiologie, Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke, Arthur-Scheunert-Allee 114-116, Nuthetal, Germany.
Dtsch Arztebl Int. 2010 Jul;107(26):470-6. doi: 10.3238/arztebl.2010.0470. Epub 2010 Jul 2.
Current guidelines for assessing the risk of developing type 2 diabetes mellitus (DM) recommend using the patient's body-mass index (BMI) as a primary measure. Waist circumference measurement is recommended for overweight or obese patients only (BMI > or = 25).
We studied the interaction between BMI and waist circumference with respect to the risk of developing type 2 DM in a cohort of 9753 men and 15491 women, aged 35 to 65, who participated in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam. The statistical analysis was performed with multivariable-adjusted Cox proportional hazard regression.
During a mean follow-up interval of 8 years, type 2 DM was newly diagnosed in 583 men and 425 women. A statistically significant interaction was found between BMI and waist circumference with respect to the risk of type 2 DM (p<0.0001). The positive association between waist circumference and diabetes risk was stronger in persons with lower BMI. The relative risk (RR) of developing type 2 DM among persons of low or normal weight (BMI < 25) who had a large waist circumference was at least as high as that among overweight persons (BMI 25-29.9) with a small waist circumference: for the first case, the RR was 3.62 [1.67-7.83] in men and 2.74 [1.52-4.94] in women; for the second case, the RR was 2.26 [1.51-3.37] in men and 1.40 [0.61-3.19] in women (The figures in square brackets are 95% confidence intervals). These relative risks were calculated in comparison to the risk among persons of low or normal weight (BMI < 25) with a small waist circumference.
These findings imply that the waist circumference is an important additional piece of information for assessing the risk of type 2 DM, particularly among persons of low or normal weight.
目前评估 2 型糖尿病(DM)发病风险的指南建议将患者的体重指数(BMI)作为主要衡量标准。对于超重或肥胖患者(BMI≥25),建议进行腰围测量。
我们在欧洲癌症与营养前瞻性调查(EPIC)-波茨坦队列中,对 9753 名男性和 15491 名年龄在 35 至 65 岁之间的参与者进行了研究,分析 BMI 与腰围对 2 型 DM 发病风险的相互作用。使用多变量调整的 Cox 比例风险回归进行统计学分析。
在平均 8 年的随访期间,583 名男性和 425 名女性新诊断出 2 型 DM。BMI 与腰围之间存在统计学显著的交互作用(p<0.0001)。BMI 较低的人群中腰围与糖尿病风险之间存在较强的正相关关系。低体重或正常体重(BMI<25)且腰围较大的人群发生 2 型 DM 的相对风险(RR)至少与腰围较小的超重人群(BMI 25-29.9)相当:前者的 RR 在男性中为 3.62[1.67-7.83],在女性中为 2.74[1.52-4.94];后者的 RR 在男性中为 2.26[1.51-3.37],在女性中为 1.40[0.61-3.19]。这些相对风险是与低体重或正常体重(BMI<25)且腰围较小的人群的风险进行比较得出的。
这些发现表明,腰围是评估 2 型 DM 发病风险的重要附加信息,特别是在低体重或正常体重的人群中。